Immix Biopharma, Inc. (IMMX)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch IMMX
See up to 3 months of IMMX. The 7-day demo opens the 1M and 3M ranges and puts IMMX on your watchlist.
Start 7-day demoLatest IMMX insider trades
About Immix Biopharma, Inc. (IMMX)
The SEC lists Immix Biopharma, Inc. under CIK 0001873835, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
IMMX Form 4 activity by transaction type, last 90 days
No Form 4 activity for IMMX in the last 90 days.
IMMX insider transactions (Form 4)
2615 Form 4 filings on record, the earliest from Dec 26, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Helen C. Adams - Director | Grant or award | Common Stock | 6,250 footnote F1 | $0.00 | - | |
| Helen C. Adams - Director | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| ||||||
| Carey Ng - Director | Grant or award | Common Stock | 6,250 footnote F1 | $0.00 | - | |
| Carey Ng - Director | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| ||||||
| Magda Marquet - Director | Grant or award | Common Stock | 6,250 footnote F1 | $0.00 | - | |
| Magda Marquet - Director | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| ||||||
| Gabriel S. Morris - Officer | Grant or award | Stock Option (Right to Buy) | 500,000 | $0.00 | - | |
| Nancy T. Chang - Director | Grant or award | Common Stock | 6,250 footnote F1 | $0.00 | - | |
| Nancy T. Chang - Director | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| ||||||
| Ilya M. Rachman - Officer | Grant or award | Stock Option (Right to Buy) | 500,000 | $0.00 | - | |
| Yekaterina Chudnovsky - Director | Grant or award | Common Stock | 6,250 footnote F1 | $0.00 | - | |
| Yekaterina Chudnovsky - Director | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| ||||||
| Jason Hsu - Director | Grant or award | Common Stock | 6,250 footnote F1 | $0.00 | - | |
| Jason Hsu - Director | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| ||||||
| Jane Buchan - Director | Grant or award | Common Stock | 6,250 footnote F1 | $0.00 | - | |
| Jane Buchan - Director | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| ||||||
| Nancy T. Chang - Director | Grant or award | Stock Option (Right to Buy) | 39,643 | $0.00 | - | |
| Ilya M. Rachman - Officer | Open-market purchase | Common Stock | 746 | $6.67 | $5K | |
| Gabriel S. Morris - Officer | Open-market purchase | Common Stock | 770 | $6.58 | $5K | |
| Gabriel S. Morris - Officer | Other | Common Stock | 156,000 | $0.80 | $125K | |
| Gabriel S. Morris - Officer | Other | Warrants (right to purchase) | 96,000 | $0.00 | - | |
| Gabriel S. Morris - Officer | Other | Warrants (right to purchase) | 60,000 | $0.00 | - | |
| Ilya M. Rachman - Officer | Open-market purchase | Common Stock | 2,500 | $2.02 | $5K | |
| Gabriel S. Morris - Officer | Open-market purchase | Common Stock | 2,600 | $1.97 | $5K | |
| Jason Hsu - Director | Open-market purchase | Common Stock | 7,700 | $2.17 | $17K | |
| Jason Hsu - Director | Open-market purchase | Common Stock | 40,000 | $2.19 | $88K | |
Item 8.01, 9.01
Item 7.01, 8.01, 9.01
Item 8.01
Item 5.07
IMMX insider trading FAQ
What is the latest insider trade for IMMX?
Immix Biopharma, Inc. (IMMX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-29. The full record for IMMX runs to 15 Form 4 filings, the earliest from 2024-12-26. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IMMX stock?
No insider purchases of IMMX were filed in the last 90 days. 6 purchases are on record for this company.
How many insiders are selling IMMX stock?
No insider sales of IMMX were filed in the last 90 days.
Where can I see IMMX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IMMX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Helen C. Adams view on EDGAR
- - Carey Ng view on EDGAR
- - Magda Marquet view on EDGAR
- - Gabriel S. Morris view on EDGAR
- - Nancy T. Chang view on EDGAR
- - Ilya M. Rachman view on EDGAR
- - Yekaterina Chudnovsky view on EDGAR
- - Jason Hsu view on EDGAR
- - Jane Buchan view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where IMMX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IMMX with a 7-day demo
- IMMX on your watchlist
- Every IMMX Form 4 filing on record
- Up to 3 months of IMMX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
